DK1353953T3 - MU-1, medlem af cytokin receptor familien - Google Patents
MU-1, medlem af cytokin receptor familienInfo
- Publication number
- DK1353953T3 DK1353953T3 DK01937340T DK01937340T DK1353953T3 DK 1353953 T3 DK1353953 T3 DK 1353953T3 DK 01937340 T DK01937340 T DK 01937340T DK 01937340 T DK01937340 T DK 01937340T DK 1353953 T3 DK1353953 T3 DK 1353953T3
- Authority
- DK
- Denmark
- Prior art keywords
- receptor family
- cytokine receptor
- disclosed
- fragments
- proteins
- Prior art date
Links
- 102000003675 cytokine receptors Human genes 0.000 title 1
- 108010057085 cytokine receptors Proteins 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56938400A | 2000-05-11 | 2000-05-11 | |
| PCT/US2001/015395 WO2001085792A2 (en) | 2000-05-11 | 2001-05-11 | Mu-1, member of the cytokine receptor family |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1353953T3 true DK1353953T3 (da) | 2007-04-16 |
Family
ID=24275231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01937340T DK1353953T3 (da) | 2000-05-11 | 2001-05-11 | MU-1, medlem af cytokin receptor familien |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP1787997A1 (da) |
| JP (3) | JP2004500845A (da) |
| AT (1) | ATE346864T1 (da) |
| AU (2) | AU6308801A (da) |
| CY (1) | CY1107339T1 (da) |
| DE (1) | DE60124954T2 (da) |
| DK (1) | DK1353953T3 (da) |
| ES (1) | ES2276795T3 (da) |
| PT (1) | PT1353953E (da) |
| WO (1) | WO2001085792A2 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6057128A (en) | 1998-03-17 | 2000-05-02 | Genetics Institute, Inc. | MU-1, member of the cytokine receptor family |
| EP3254687A1 (en) | 2001-10-04 | 2017-12-13 | Genetics Institute LLC | Methods and compositions for modulating interleukin-21 receptor activity |
| WO2003064469A2 (en) * | 2002-02-01 | 2003-08-07 | Bayer Healthcare Ag | Regulation of human hematopoietin receptor-like protein |
| MXPA05000655A (es) | 2002-07-15 | 2006-02-22 | Harvard College | Metodos y composiciones para modular el desarrollo y la funcion de las celulas t helper (th). |
| EP1449883A1 (en) * | 2003-02-18 | 2004-08-25 | Corus Technology BV | Polymer packaging layer with improved release properties |
| CA2518371A1 (en) * | 2003-03-14 | 2004-09-30 | Wyeth | Antibodies against human il-21 receptor and uses therefor |
| GT200600148A (es) | 2005-04-14 | 2006-11-22 | Metodos para el tratamiento y la prevencion de fibrosis | |
| WO2009143526A1 (en) | 2008-05-23 | 2009-11-26 | Wyeth | Methods of treatment utilizing binding proteins of the interleukin-21 receptor |
| AR071885A1 (es) | 2008-05-23 | 2010-07-21 | Wyeth Corp | Proteinas de union al receptor de interleuquina 21 |
| CA2739357A1 (en) | 2008-09-23 | 2010-04-08 | Wyeth Llc | Methods for predicting production of activating signals by cross-linked binding proteins |
| WO2015110930A1 (en) | 2014-01-24 | 2015-07-30 | Pfizer Inc. | Modified interleukin 21 receptor proteins |
| US12012441B2 (en) | 2020-10-26 | 2024-06-18 | Neptune Biosciences Llc | Engineered human IL-21 cytokines and methods for using the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6057128A (en) * | 1998-03-17 | 2000-05-02 | Genetics Institute, Inc. | MU-1, member of the cytokine receptor family |
| AU759689B2 (en) * | 1998-06-24 | 2003-04-17 | Chugai Seiyaku Kabushiki Kaisha | Novel hemopoietin receptor proteins |
| DE69941126D1 (de) * | 1998-09-23 | 2009-08-27 | Zymogenetics Inc | Cytokinerezeptor zalpha11 |
| WO2000069880A1 (en) * | 1999-05-18 | 2000-11-23 | Millennium Pharmaceuticals, Inc. | Il-9/il-2 receptor-like molecules and uses thereof |
| WO2001077171A2 (en) * | 2000-04-05 | 2001-10-18 | Zymogenetics, Inc. | Soluble zalpha11 cytokine receptors |
-
2001
- 2001-05-11 PT PT01937340T patent/PT1353953E/pt unknown
- 2001-05-11 JP JP2001582391A patent/JP2004500845A/ja active Pending
- 2001-05-11 EP EP06124726A patent/EP1787997A1/en not_active Withdrawn
- 2001-05-11 EP EP01937340A patent/EP1353953B1/en not_active Expired - Lifetime
- 2001-05-11 AU AU6308801A patent/AU6308801A/xx active Pending
- 2001-05-11 DE DE60124954T patent/DE60124954T2/de not_active Expired - Lifetime
- 2001-05-11 DK DK01937340T patent/DK1353953T3/da active
- 2001-05-11 AT AT01937340T patent/ATE346864T1/de active
- 2001-05-11 WO PCT/US2001/015395 patent/WO2001085792A2/en not_active Ceased
- 2001-05-11 ES ES01937340T patent/ES2276795T3/es not_active Expired - Lifetime
- 2001-05-11 AU AU2001263088A patent/AU2001263088B2/en not_active Expired
-
2007
- 2007-02-20 CY CY20071100239T patent/CY1107339T1/el unknown
-
2008
- 2008-06-19 JP JP2008161010A patent/JP2009019037A/ja active Pending
-
2011
- 2011-12-27 JP JP2011286773A patent/JP5763518B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001085792A3 (en) | 2003-08-21 |
| JP2004500845A (ja) | 2004-01-15 |
| EP1353953A2 (en) | 2003-10-22 |
| ES2276795T3 (es) | 2007-07-01 |
| DE60124954D1 (de) | 2007-01-11 |
| AU2001263088B2 (en) | 2006-07-20 |
| JP5763518B2 (ja) | 2015-08-12 |
| AU2001263088C1 (en) | 2001-11-20 |
| DE60124954T2 (de) | 2007-09-20 |
| JP2009019037A (ja) | 2009-01-29 |
| CY1107339T1 (el) | 2012-12-19 |
| PT1353953E (pt) | 2007-02-28 |
| AU6308801A (en) | 2001-11-20 |
| EP1353953B1 (en) | 2006-11-29 |
| JP2012061009A (ja) | 2012-03-29 |
| WO2001085792A2 (en) | 2001-11-15 |
| WO2001085792A8 (en) | 2002-05-23 |
| EP1787997A1 (en) | 2007-05-23 |
| ATE346864T1 (de) | 2006-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0994947T3 (da) | MU-1-medlem af cytokinreceptorfamilien | |
| CY1107339T1 (el) | Mu-1, μελος της οικογενειας υποδοχεα κυτοκινης | |
| DK1259547T3 (da) | Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf | |
| CY2014038I1 (el) | Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| NO20030614L (no) | Anti-IL-12-antistoffer, sammensetninger, fremgangsmåter og anvendelser | |
| IS7576A (is) | And-mýelíntengd glýkóprótín (MAG) mótefni | |
| DK1390389T3 (da) | Cripto-blokerende antistoffer og anvendelser deraf | |
| NO20040398L (no) | Hydrofobe assosiative polymerer, blandinger med slike og anvendelse av slike. | |
| DE602004006169D1 (de) | Substituierte 8'-pyri(mi)dinyl-dihydrospiro-äcycloalkylaminü-pyrimidoä1,2aüpyrimidin-6-onderivate | |
| NO20042474L (no) | Reguleringsventil-stromningsjusteringsanordning. | |
| NO20035049D0 (no) | Fysisk kanalkonfigureringssignalprosedyre | |
| ES1049710Y (es) | Pieza ceramica, azulejo, baldosa o similares, mejorada. | |
| DE60215473D1 (de) | Asymmetrische dendriten | |
| DE60221412D1 (de) | Zonensteuerung | |
| DK1141286T3 (da) | Kæde af cytokinreceptorer | |
| DE60227657D1 (de) | 1-OXA-3,9-DIAZASPIROc5.5ÜUNDECAN-2-ONDERIVATE UND ZEPTORS | |
| EP1359932A4 (en) | TIP39 POLYPEPTIDES | |
| WO2002064630A3 (en) | Il-1 receptor accessory protein | |
| EP1462969A4 (en) | PRICE DRAW SYSTEM | |
| DK1303539T3 (da) | Hidtil ukendt medlem af EphA-receptorfamilien | |
| DZ3441A1 (fr) | Nouvelles phenylpiperazines. | |
| DE69930370D1 (de) | Testisspezifische, menschliche proteinase, svph1-8 | |
| ITTO20020811A1 (it) | Buffer d'uscita con comando rapido. | |
| ES1049767Y (es) | Señal de trafico. | |
| ES1051609Y (es) | Canaleta clasificadora. |